Migraine: Epidemiology, Risk Factors, Pathophysiology, and Treatment
Weiwei Lu, Yuan Zhang, Chen Shi, Yu Tao, Shaoxin Li, Yufang Sun, Fuhai Ji, Dongsheng Jiang, Terrance P Snutch, Jin Tao · 2026
Read Migraine: Epidemiology, Risk Factors, Pathophysiology, and Treatment by Weiwei Lu, Yuan Zhang, Chen Shi, Yu Tao, Shaoxin Li, Yufang Sun, Fuhai Ji, Dongsheng Jiang, Terrance P Snutch, Jin Tao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13527415.txt.
Description
Weiwei Lu and nine colleagues review migraine, its spread, risk factors, body pathways, and treatment, in a paper from twenty twenty-six. Migraine disables about a billion people worldwide. Women and working-age adults bear the most of it. Once seen as a vessel headache, it is now framed as a network brain disorder. Genes, hormones, environment, and several brain systems interact in it.
The review covers global patterns, sex-specific and environmental risks, and the slide from episodic to chronic attacks. Body pathway sections treat spreading depolarization, trigeminovascular signaling, and inflammation. New peptide-targeted drugs, oral preventives, antibodies, and neuromodulation are assessed. Special groups like children, older adults, and pregnant patients get their own focus. Gaps remain in how patients are sorted and in halting chronification. The authors push biomarker work and precision medicine for fairer care.
Catalog record
| CREATOR | Weiwei Lu, Yuan Zhang, Chen Shi, Yu Tao, Shaoxin Li, Yufang Sun, Fuhai Ji, Dongsheng Jiang, Terrance P Snutch, Jin Tao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 157 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |